Panagora Asset Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
LCM
Panagora Asset Management's CCCC Position: Q3 2026 in Review
Panagora Asset Management increased its C4 Therapeutics (CCCC) stake by 161% in Q3 2026, buying an estimated $1.59M and bringing the position to 690,687 shares worth $2.3M. The position accounts for 0.01% of the portfolio, ranked #612.
Panagora Asset Management first reported a position in CCCC in Q1 2023 and has held it in 4 quarters since. 146 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.
- Panagora Asset Management held 690,687 shares of C4 Therapeutics worth $2.3M as of Q3 2026.
- Panagora Asset Management bought 425,740 C4 Therapeutics shares in Q3 2026, an estimated $1.59M.
- C4 Therapeutics made up 0.01% of Panagora Asset Management's portfolio in Q3 2026, its #612 holding.
- Panagora Asset Management first reported a position in C4 Therapeutics in Q1 2023 and has held it in 4 quarters since.
- 146 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.
Based on Panagora Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.